An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism—the German perspective

Surgery ◽  
2010 ◽  
Vol 148 (6) ◽  
pp. 1091-1099 ◽  
Author(s):  
Ralph Schneider ◽  
Georgios Kolios ◽  
Benjamin M. Koch ◽  
Emilio Domínguez Fernández ◽  
Detlef K. Bartsch ◽  
...  
2006 ◽  
Vol 26 (11) ◽  
pp. 629-638 ◽  
Author(s):  
Hubertus Rosery ◽  
Rito Bergemann ◽  
Steven E Marx ◽  
Axel Boehnke ◽  
Joel Melnick ◽  
...  

2017 ◽  
Vol 20 (2) ◽  
pp. 63-68 ◽  
Author(s):  
Lilit V. Egshatyan ◽  
Natalya G. Mokrisheva ◽  
Lyudmila Ya. Rozhinskaya

In the treatment of secondary hyperparathyroidism of end-stage chronic kidney disease, vitamin D receptor activation and allosteric modulators of the calcium-sensing receptor – inhibit glandular hyperplasia, reduce parathyroid hormone levels, impact on bone turnover and mineral density. But the use of calcimimetic and vitamin D analogs or mimetics did not reduce the need for parathyroidectomy for refractory hyperparathyroidism. The enlarged parathyroid gland and gland nodular transformation became refractory to medical therapy and patient need for parathyroidectomy. Tertiary hyperparathyroidism is a state of excessive secretion of parathyroid hormone after a long period of secondary hyperparathyroidism and renal transplantation. In this article, we present the case of a Caucasian male with chronic kidney disease (end-stage on chronic hemodialysis and after kidney transplantation) and different forms of hyperparathyroidism (secondary and tertiary). Our case study shows that only a multi-interventional strategy is likely to be more effective treatment in cases of severe and refractory to medical therapy hyperparathyroidism.


2018 ◽  
Vol 47 (1-3) ◽  
pp. 37-44 ◽  
Author(s):  
Carlo Alfieri ◽  
Anna Regalia ◽  
Francesca Zanoni ◽  
Simone Vettoretti ◽  
Mario Cozzolino ◽  
...  

Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients’ point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.


2010 ◽  
Vol 20 (5) ◽  
pp. S64-S70 ◽  
Author(s):  
Rosa Maria De Santo ◽  
Antonio Livrea ◽  
Natale G. De Santo ◽  
Giovanni Conzo ◽  
Giancarlo Bilancio ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 488-488
Author(s):  
Folke Schmidt ◽  
Simon Ldsch ◽  
Ludger Franzaring ◽  
Joachim W. Thüroff

Sign in / Sign up

Export Citation Format

Share Document